Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements

Hormone Research

Volumn 69, Issue 5, 2008, Pages 295-300

  Chia, Victoria M ^a,b   Newcomb, Polly A ^a,b   White, Emily ^a,b   Zheng, Yingye ^a   Potter, John D ^a,b   Lampe, Johanna W ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Insulin like growth factor binding protein 3; Insulin like growth factor I; Leptin; Reproducibility; Serum

Indexed keywords

LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; REPRODUCIBILITY; WEIGHT CHANGE;

ADULT; BODY WEIGHT; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 43749096783     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000114861     Document Type: Article

References (19)

1. Ren J: Leptin and hyperleptinemia: from friend to foe for cardiovascular function. J Endocrinol 2004;181:1-10.
2. Kaplan RC, Strickler HD, Rohan TE, Muzumdar R, Brown DL: Insulin-like growth factors and coronary heart disease. Cardiol Rev 2005;13:35-39.
3. Gola M, Bonadonna S, Doga M, Giustina A: Clinical review: growth hormone and cardiovascular risk factors. J Clin Endocrinol Metab 2005;90:1864-1870.
4. Somasundar P, McFadden DW, Hileman SM, Vona-Davis L: Leptin is a growth factor in cancer. J Surg Res 2004;116:337-349.
5. Giovannucci E: Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704.
6. Mills PJ, Ziegler MG, Morrison TA: Leptin is related to epinephrine levels but not reproductive hormone levels in cycling African-American and Caucasian women. Life Sci 1998;63:617-623.
7. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M: Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998;279:563-566.
8. Goodman-Gruen D, Barrett-Connor E: Epidemiology of insulin-like growth factor-I in elderly men and women: The Rancho Bernardo Study. Am J Epidemiol 1997;145:970-976.
9. Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL: Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 2004;89:2271-2274.
10. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE: Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 2006;15:972-978.
11. DSL-10-23100 ACTIVE Human Leptin Enzyme-Linked Immunosorbent (ELISA) Kit, Package insert, July 2003.
12. DLS-10-2800 ACTIVE Non-Extraction IGF-I Enzyme-Liked Immunosorbent Assay (ELISA) Kit, Package insert, April 2004.
13. DSL-10-6600 ACTIVE IGFBP-3 Enzyme-Liked Immunosorbent Assay (ELISA) Kit, Package insert, July 2003.
14. Fleiss JL: The Design and Analysis of Clinical Experiments. New York, Wiley, 1986.
15. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE: Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-654.
16. Rosner B: Fundamentals of Biostatistics, ed 5. Pacific Grove, Duxbury Press, 2000.
17. Fleiss JL, Levin B, Paik MC: Statistical Methods for Rates and Proportions, ed 3. Hoboken, Wiley, 2003.
18. Armstrong BK, White E, Saracci R: Principles of Exposure Measurement in Epidemiology. Oxford, Oxford University Press, 1992.
19. Liu J, Askari H, Dagogo-Jack S: Reproducibility of fasting plasma leptin concentration in lean and obese humans. Endocr Res 1999;25:1-10.